As described in the Introduction section, this blockage, which can happen either in the earlier stage of antigen presentation (CTLA4-B7) or later at the tumor site (PD-1/PL-L1), efficiently reactivates the T cells to recognize and eliminate cancer cells (Figure 2) [208]. This evidence concerns the gene CTLA4 and neoplasm.